[The status of precision medicine in Hungary in the light of European practice].

Abstract

Background and aim: Molecular genetic diagnostics is a complex process, most modern laboratory technologies, IT procedures, data management, medical decision support systems, databases and algorithms are used together. Oncological treatments are expensive procedures and the effectiveness of individual therapies varies in different subtypes of cancer. Nowadays, agnostic approach is increasingly emerging in oncological treatments, i.e. the unique characteristics of the tumors determines the therapeutic direction for each patient. With the development of diagnostic technologies, more and more data are being collected about the biology and genetic characteristics of tumors. Our current work summarizes the milestones of precision oncology and presents those European projects which focus on elimination of inequalities between countries.

Results: Milestones of domestic precision medicine oncology program have been closely linked to European initiatives.

Conclusion: The developed and introduced procedures in Hungary are unique among European countries and resulted in a significant improvement of patient care.